Dyne Therapeutics Ownership | Who Owns Dyne Therapeutics?
Dyne Therapeutics Ownership Summary
Dyne Therapeutics is owned by 111.02% institutional investors, 0.48% insiders. Atlas venture life science advisors is the largest institutional shareholder, holding 9.90% of DYN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.59% of its assets in Dyne Therapeutics shares.
DYN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Dyne Therapeutics | 111.02% | 0.48% | -11.50% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Atlas venture life science advisors | 8.02M | 9.90% | $283.03M |
Fcpm iii services b.v. | 7.85M | 9.68% | $276.86M |
Blackrock | 7.39M | 9.11% | $260.69M |
Rtw investments, lp | 6.39M | 7.88% | $225.40M |
Ra capital management | 6.05M | 7.46% | $213.48M |
Fmr | 5.32M | 6.56% | $187.71M |
Vanguard group | 4.72M | 5.82% | $166.50M |
Janus henderson group | 4.62M | 5.71% | $163.24M |
Deep track capital, lp | 4.00M | 4.94% | $141.16M |
Adage capital partners gp | 3.33M | 4.11% | $117.45M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Fcpm iii services b.v. | 7.85M | 40.83% | $276.86M |
Mpm asset management | 1.56M | 30.26% | $55.11M |
Atlas venture life science advisors | 8.02M | 29.80% | $283.03M |
Vida ventures advisors | 407.50K | 15.73% | $14.38M |
Tcg crossover management | 2.65M | 9.75% | $93.52M |
Octagon capital advisors lp | 1.18M | 6.55% | $41.67M |
Acuta capital partners | 212.50K | 6.32% | $7.50M |
Vivo capital | 1.64M | 5.33% | $57.70M |
Vr adviser | 2.17M | 4.89% | $76.72M |
Deep track capital, lp | 4.00M | 4.21% | $141.16M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rtw investments, lp | 6.39M | 3.49% | 3.30M |
Fmr | 5.32M | 0.01% | 2.10M |
Holocene advisors, lp | 2.08M | 0.31% | 2.08M |
Blackrock | 7.39M | 0.01% | 2.00M |
Janus henderson group | 4.62M | 0.09% | 1.95M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Mpm asset management | 1.56M | 30.26% | -1.89M |
Logos global management lp | 265.00K | 0.75% | -1.47M |
State street | 3.20M | 0.00% | -992.58K |
Deep track capital, lp | 4.00M | 4.21% | -555.38K |
Lmr partners llp | - | - | -477.00K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Holocene advisors, lp | 2.08M | 0.31% | 2.08M | $73.27M |
Eventide asset management | 485.00K | 0.29% | 485.00K | $17.12M |
Pictet asset management sa | 294.75K | 0.01% | 294.75K | $10.40M |
Soleus capital management | 201.00K | 0.63% | 201.00K | $7.09M |
Avoro capital advisors | 115.75K | 0.05% | 115.75K | $4.08M |
Sold Out
Holder | Change |
---|---|
Headlands | -1.00 |
Nelson, van denburg & campbell wealth management group | -9.00 |
Innealta capital | -81.00 |
Adar1 capital management | -297.00 |
Truvestments capital | -464.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 207 | 5.08% | 111,994,758 | 0.90% | 111 | 0.59% | 117 | -7.14% | 54 | 17.39% |
Jun 30, 2024 | 197 | 12.57% | 110,993,406 | 16.43% | 136 | 0.99% | 126 | -1.56% | 46 | 58.62% |
Mar 31, 2024 | 175 | 28.68% | 95,333,552 | 36.34% | 117 | 0.91% | 128 | 85.51% | 29 | -27.50% |
Dec 31, 2023 | 136 | 13.33% | 69,922,234 | 16.75% | 113 | 1.19% | 69 | 16.95% | 40 | 25.00% |
Sep 30, 2023 | 120 | - | 59,888,841 | 1.18% | 98 | 1.00% | 59 | -18.06% | 32 | 14.29% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 2.64M | 2.59% | -13.39K |
iShares Russell 2000 ETF | 2.27M | 2.23% | -4.75K |
Fidelity Growth Compy Commingled Pl S | 1.80M | 1.79% | 14.65K |
Fidelity Growth Compy Commingled Pl O | 1.79M | 1.78% | 348.61K |
SPDR® S&P Biotech ETF | 1.81M | 1.78% | -54.90K |
Janus Henderson Global Life Sciences | 1.42M | 1.42% | 227.22K |
Janus Henderson Global Life Sciences D | 1.42M | 1.40% | 273.25K |
Fidelity Growth Company Fund | 1.33M | 1.33% | 12.87K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.17M | 1.15% | -4.31K |
Janus Henderson Glb Life Scn I2 USD | 1.09M | 1.07% | 31.93K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 11, 2024 | Beskrovnaya Oxana | Chief Scientific Officer | Sell | $65.63K |
Dec 11, 2024 | Scalzo Richard William | SVP, Head of Finance & Admin. | Sell | $40.91K |
Dec 09, 2024 | Kersten Dirk | - | Sell | $1.00M |
Dec 06, 2024 | Kersten Dirk | - | Sell | $2.98M |
Dec 05, 2024 | Kersten Dirk | - | Sell | $110.56K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 24 |
2024 Q3 | 2 | 79 |
2024 Q2 | - | 26 |
2024 Q1 | 2 | 122 |
2023 Q4 | - | 11 |
DYN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools